| Claire Gerlitz, PT, DPT | |
|
12100 Black Swan Dr Ste 202, Lewes, DE 19958-4991 | |
| (302) 449-6476 | |
| (302) 449-2047 |
| Full Name | Claire Gerlitz |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 2 Years |
| Location | 12100 Black Swan Dr Ste 202, Lewes, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346970175 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | J1-0014545 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Physical Therapy And Sports Performance Limited Partnership | 2668774167 | 40 |
News Archive
Induced pluripotent stem cells (iPS cells) are truly talented multi-taskers. They can reproduce almost all cell types and thus offer great hope in the fight against diseases like Alzheimer's and Parkinson's. However, it would appear that their use is not entirely without risk: during the reprogramming of body cells into iPS cells, disease-causing mutations can creep into the genetic material.
Sons of older fathers are more intelligent, more focused on their interests, and less concerned about fitting in, all characteristics typically seen in "geeks," according to research conducted at The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and published on June 20 in the journal Translational Psychiatry.
Genentech, a member of the Roche Group, today announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous (SC) formulation of ACTEMRA (tocilizumab) 162mg weekly compared to 8 mg/kg ACTEMRA intravenous (IV) formulation every four weeks.
A new study examining the role that star-shaped brain cells called astrocytes play in Huntington's disease has identified a potential strategy that may halt the disease and repair some of the damage it causes.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
› Verified 9 days ago
| Provider Name | Premier Physical Therapy And Sports Performance Limited Partnership |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1417320151 PECOS PAC ID: 2668774167 Enrollment ID: O20151230000159 |
News Archive
Induced pluripotent stem cells (iPS cells) are truly talented multi-taskers. They can reproduce almost all cell types and thus offer great hope in the fight against diseases like Alzheimer's and Parkinson's. However, it would appear that their use is not entirely without risk: during the reprogramming of body cells into iPS cells, disease-causing mutations can creep into the genetic material.
Sons of older fathers are more intelligent, more focused on their interests, and less concerned about fitting in, all characteristics typically seen in "geeks," according to research conducted at The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and published on June 20 in the journal Translational Psychiatry.
Genentech, a member of the Roche Group, today announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous (SC) formulation of ACTEMRA (tocilizumab) 162mg weekly compared to 8 mg/kg ACTEMRA intravenous (IV) formulation every four weeks.
A new study examining the role that star-shaped brain cells called astrocytes play in Huntington's disease has identified a potential strategy that may halt the disease and repair some of the damage it causes.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Claire Gerlitz, PT, DPT 1050 Industrial Dr Ste 210, Middletown, DE 19709-2803 Ph: (302) 449-6476 | Claire Gerlitz, PT, DPT 12100 Black Swan Dr Ste 202, Lewes, DE 19958-4991 Ph: (302) 449-6476 |
News Archive
Induced pluripotent stem cells (iPS cells) are truly talented multi-taskers. They can reproduce almost all cell types and thus offer great hope in the fight against diseases like Alzheimer's and Parkinson's. However, it would appear that their use is not entirely without risk: during the reprogramming of body cells into iPS cells, disease-causing mutations can creep into the genetic material.
Sons of older fathers are more intelligent, more focused on their interests, and less concerned about fitting in, all characteristics typically seen in "geeks," according to research conducted at The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and published on June 20 in the journal Translational Psychiatry.
Genentech, a member of the Roche Group, today announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy (non-inferiority) of the subcutaneous (SC) formulation of ACTEMRA (tocilizumab) 162mg weekly compared to 8 mg/kg ACTEMRA intravenous (IV) formulation every four weeks.
A new study examining the role that star-shaped brain cells called astrocytes play in Huntington's disease has identified a potential strategy that may halt the disease and repair some of the damage it causes.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
› Verified 9 days ago
Danielle Spagnolo, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 701 Savannah Rd Ste A1, Lewes, DE 19958 Phone: 302-644-2530 Fax: 302-644-2556 | |
Ross Mathew Haley, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 20268 Plantations Rd, Suite B, Lewes, DE 19958 Phone: 302-727-0075 Fax: 302-727-2047 | |
Ellie Wolfenden, Physical Therapist Medicare: Medicare Enrolled Practice Location: 701 Savannah Rd, Lewes, DE 19958 Phone: 302-644-2530 | |
Mr. Eric Reinhold, MPT, ATC Physical Therapist Medicare: Medicare Enrolled Practice Location: 701 Savannah Rd, Suite A-1, Lewes, DE 19958 Phone: 302-644-2530 Fax: 302-644-2556 | |
Joseph Whalen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Peddlers Vlg, Suite A1, Lewes, DE 19958 Phone: 410-822-4613 Fax: 410-822-6534 | |
Mariah Jane Osgood, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20268 Plantations Rd # B, Lewes, DE 19958 Phone: 302-727-0075 Fax: 302-449-2047 | |
Ebs Childrens Therapy Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1143 Savannah Rd Ste 4, Lewes, DE 19958 Phone: 302-332-9736 Fax: 302-644-2272 |